1 – 10 of 195
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
- Contribution to journal › Article
-
Mark
Medial temporal lobe atrophy is associated with age and pathologies, especially small vessel disease
- Contribution to journal › Article
-
Mark
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
- Contribution to journal › Article
-
Mark
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
- Contribution to journal › Article
-
Mark
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
- Contribution to journal › Article
-
Mark
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
- Contribution to journal › Article
-
Mark
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression : a randomized placebo-controlled trial
(2026) In Nature Medicine
- Contribution to journal › Article
-
Mark
Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
- Contribution to journal › Article
- 2025
-
Mark
Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease
- Contribution to journal › Article
